相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Recent insights in the PI3K/Akt pathway as a promising therapeutic target in combination with EGFR-targeting agents to treat head and neck squamous cell carcinoma
Hannah Zaryouh et al.
MEDICINAL RESEARCH REVIEWS (2022)
Observational, prospective, phase 4 study in patients with first-line recurrent and/or metastatic squamous cell carcinoma of the head and neck treated with cetuximab and platinum-based therapy: DIRECT
Joel Guigay et al.
CANCER REPORTS (2022)
Unraveling most abundant mutational signatures in head and neck cancer
Michaela Plath et al.
INTERNATIONAL JOURNAL OF CANCER (2021)
Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma
Chen Huang et al.
CANCER CELL (2021)
Efficacy of Afatinib in the Treatment of Patients with Non-Small Cell Lung Cancer and Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis
Nian N. N. Maarof et al.
CANCERS (2021)
The immune microenvironment in EGFR- and ERBB2-mutated lung adenocarcinoma
M. Kirchner et al.
ESMO OPEN (2021)
Identification of prognostic values defined by copy number variation, mRNA and protein expression of LANCL2 and EGFR in glioblastoma patients
Hua-fu Zhao et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2021)
Both combined or sequential use with immune checkpoint inhibitors on cetuximab-treated patients with recurrent or metastatic head and neck squamous cell carcinoma improve the overall survival
Ming-Yu Lien et al.
ORAL ONCOLOGY (2021)
The mutational landscape of early- and typical-onset oral tongue squamous cell carcinoma
Benjamin R. Campbell et al.
CANCER (2021)
Extended 5-Year Follow-up Results of a Phase Ib Study (BRIM7) of Vemurafenib and Cobimetinib in BRAF-Mutant Melanoma
Antoni Ribas et al.
CLINICAL CANCER RESEARCH (2020)
Genome-wide profiling of non-smoking-related lung cancer cells reveals common RB1 rearrangements associated with histopathologic transformation in EGFR-mutant tumors
E. Pros et al.
ANNALS OF ONCOLOGY (2020)
The repertoire of mutational signatures in human cancer
Ludmil B. Alexandrov et al.
NATURE (2020)
Management of recurrent and metastatic oral cavity cancer: Raising the bar a step higher
Petr Szturz et al.
ORAL ONCOLOGY (2020)
Spectrum of EGFR aberrations and potential clinical implications: insights from integrative pan-cancer analysis
Haijing Liu et al.
CANCER COMMUNICATIONS (2020)
Updated overall survival and final progression-free survival data for patients with treatment-naive advanced ALK-positive non-small-cell lung cancer in the ALEX study
T. Mok et al.
ANNALS OF ONCOLOGY (2020)
Tumor immune microenvironment of EGFR-mutant non-small-cell lung cancer and its impact on therapeutic efficacy
Yoshiya Matsumoto et al.
IMMUNOTHERAPY (2020)
Whole genome, transcriptome and methylome profiling enhances actionable target discovery in high-risk pediatric cancer
Marie Wong et al.
NATURE MEDICINE (2020)
The incidence of squamous cell carcinoma of the oral tongue is rising in young non-smoking women: An international multi-institutional analysis
Laveniya Satgunaseelan et al.
ORAL ONCOLOGY (2020)
Squamous Cell Carcinoma of the Oral Tongue in Young Patients: Outcomes and Implications for Treatment
Narayana Subramaniam et al.
INDIAN JOURNAL OF SURGICAL ONCOLOGY (2020)
Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study
Jason K. Sicklick et al.
NATURE MEDICINE (2019)
Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma
C. Robert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Gender disparities in head and neck cancer chemotherapy clinical trials participation and treatment
Liliya Benchetrit et al.
ORAL ONCOLOGY (2019)
The Statistical Evaluation of Treatment and Outcomes in Head and Neck Squamous Cell Carcinoma Clinical Trials
Catherine Fortpied et al.
FRONTIERS IN ONCOLOGY (2019)
Systemic Therapy for Locally Advanced and Metastatic Non-Small Cell Lung Cancer A Review
Kathryn C. Arbour et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Pan-cancer whole-genome analyses of metastatic solid tumours
Peter Priestley et al.
NATURE (2019)
Beyond EGFR inhibition: multilateral combat strategies to stop the progression of head and neck cancer
Hyung Kwon Byeon et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2019)
EGFR amplification and expression in oral squamous cell carcinoma in young adults
V. Costa et al.
INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2018)
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update
Antonio C. Wolff et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
MutationalPatterns: comprehensive genome-wide analysis of mutational processes
Francis Blokzijl et al.
GENOME MEDICINE (2018)
Cetuximab in the treatment of advanced non-small cell lung cancer: FISHing for a miraculous catch
Lorenza Landi et al.
JOURNAL OF THORACIC DISEASE (2018)
Appropriate Sequence for Afatinib and Cisplatin Combination Improves Anticancer Activity in Head and Neck Squamous Cell Carcinoma
Eleonore Longton et al.
FRONTIERS IN ONCOLOGY (2018)
Global incidence of oral and oropharynx cancer in patients younger than 45 years versus older patients: A systematic review
Aisha A. Hussein et al.
EUROPEAN JOURNAL OF CANCER (2017)
HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and the American Society of Clinical Oncology
Angela N. Bartley et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Prognostic Factors of Oral Squamous Cell Carcinoma in Young Patients: A Systematic Review
Everton Freitas de Morais et al.
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2017)
Genome wide profiling in oral squamous cell carcinoma identifies a four genetic marker signature of prognostic significance
Vui King Vincent-Chong et al.
PLOS ONE (2017)
The EGFR Inhibitor Gefitinib Enhanced the Response of Human Oral Squamous Cell Carcinoma to Cisplatin In Vitro
Ashraf Khalil et al.
DRUGS IN R&D (2017)
Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
Zachary R. Chalmers et al.
GENOME MEDICINE (2017)
Afatinib in squamous cell carcinoma of the head and neck
Pol Specenier et al.
EXPERT OPINION ON PHARMACOTHERAPY (2016)
Co-treatment of wild-type EGFR head and neck cancer cell lines with afatinib and cisplatin
Roman C. Brands et al.
MOLECULAR MEDICINE REPORTS (2016)
Prognostic and predictive value of EGFR in head and neck squamous cell carcinoma
Paolo Bossi et al.
ONCOTARGET (2016)
Somatic Mutations and Genetic Variants of NOTCH1 in Head and Neck Squamous Cell Carcinoma Occurrence and Development
Yu-Fan Liu et al.
SCIENTIFIC REPORTS (2016)
The Ensembl Variant Effect Predictor
William McLaren et al.
GENOME BIOLOGY (2016)
Risk factors for head and neck cancer in young adults: a pooled analysis in the INHANCE consortium
Tatiana Natasha Toporcov et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2015)
Concurrence of EGFR amplification and sensitizing mutations indicate a better survival benefit from EGFR-TKI therapy in lung adenocarcinoma patients
Ling Shan et al.
LUNG CANCER (2015)
Clinical, genomic, and metagenomic characterization of oral tongue squamous cell carcinoma in patients who do not smoke
Ryan Li et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2015)
RNA-seq: impact of RNA degradation on transcript quantification
Irene Gallego Romero et al.
BMC BIOLOGY (2014)
Squamous Cell Carcinoma of the Oral Tongue in Young Non-Smokers Is Genomically Similar to Tumors in Older Smokers
Curtis R. Pickering et al.
CLINICAL CANCER RESEARCH (2014)
Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial
Yi-Long Wu et al.
LANCET ONCOLOGY (2014)
Multi-tiered genomic analysis of head and neck cancer ties TP53 mutation to 3p loss
Andrew M. Gross et al.
NATURE GENETICS (2014)
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin et al.
BIOINFORMATICS (2013)
Second-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Lung Cancers
Helena A. Yu et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2013)
Signatures of mutational processes in human cancer
Ludmil B. Alexandrov et al.
NATURE (2013)
Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells
Wanjuan Yang et al.
NUCLEIC ACIDS RESEARCH (2013)
Prognostic Significance of Tumor-Infiltrating Lymphocytes for Patients With Colorectal Cancer
Jae Hyuk Lee
ARCHIVES OF SURGERY (2012)
Trends in incidence, tumour sites and tumour stages of oral and pharyngeal cancer in Northern Germany
Katrin Hertrampf et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2012)
RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome
Bo Li et al.
BMC BIOINFORMATICS (2011)
BRAF mutations in cutaneous melanoma are independently associated with age, anatomic site of the primary tumor, and the degree of solar elastosis at the primary tumor site
Juergen Bauer et al.
PIGMENT CELL & MELANOMA RESEARCH (2011)
Allele-specific copy number analysis of tumors
Peter Van Loo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Global epidemiology of oral and oropharyngeal cancer
Saman Warnakulasuriya
ORAL ONCOLOGY (2009)
Platinum-based chemotherapy plus cetuximab in head and neck cancer
Jan B. Vermorken et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Changing Trends in Oral Squamous Cell Carcinoma with Particular Reference to Young Patients: 1971-2006. The Emory University Experience
Susan Muller et al.
HEAD & NECK PATHOLOGY (2008)
Phase II study of combination cetuximab and weekly paclitaxel in patients with metastatic/recurrent squamous cell carcinoma of head and neck (SCCHN): Spanish Head and Neck Cancer Group (TTCC)
R. Hitt et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Open-label, uncontrolled, multicenter phase II study to evaluate the efficacy and toxicity of cetuximab as a single agent in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck who failed to respond to platinum-based therapy
Jan B. Vermorken et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck
JA Bonner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Structural basis for inhibition of the epidermal growth factor receptor by cetuximab
SQ Li et al.
CANCER CELL (2005)
Incidence and survival of squamous cell carcinoma of the tongue in Scandinavia, with special reference to young adults
K Annertz et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
分享论文
